Adam R Brentnall
Overview
Explore the profile of Adam R Brentnall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
1230
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Swanton C, Bachtiar V, Mathews C, Brentnall A, Lowenhoff I, Waller J, et al.
Clin Trials
. 2025 Jan;
17407745241302477.
PMID: 39862108
Background/aims: Certain sociodemographic groups are routinely underrepresented in clinical trials, limiting generalisability. Here, we describe the extent to which enriched enrolment approaches yielded a diverse trial population enriched for older...
2.
Sasieni P, Brentnall A
J Natl Cancer Inst
. 2024 Oct;
117(3):450-455.
PMID: 39400565
Background: The NHS-Galleri Trial has demonstrated feasibility of a trial design in which all participants provide a "sample" for screening, but only samples from the intervention arm are tested and...
3.
Faheem M, Tam H, Nougom M, Suaris T, Jahan N, Lloyd T, et al.
J Breast Imaging
. 2024 Jun;
6(4):355-377.
PMID: 38912622
Background: High mammographic density increases breast cancer risk and reduces mammographic sensitivity. We reviewed evidence on accuracy of supplemental MRI for women with dense breasts at average or increased risk....
4.
Rebolj M, Brentnall A, Cuschieri K
Br J Cancer
. 2024 Apr;
130(11):1733-1743.
PMID: 38615108
Vaccination against human papillomavirus (HPV) is changing the performance of cytology as a cervical screening test, but its effect on HPV testing is unclear. We review the effect of HPV16/18...
5.
Gilham C, Nedjai B, Scibior-Bentkowska D, Reuter C, Banwait R, Brentnall A, et al.
Int J Cancer
. 2024 Mar;
155(1):81-92.
PMID: 38507581
Methylation markers have shown potential for triaging high-risk HPV-positive (hrHPV+) women to identify those at increased risk of invasive cervical cancer (ICC). Our aim was to assess the performance of...
6.
Santeramo R, Damiani C, Wei J, Montana G, Brentnall A
Breast Cancer Res
. 2024 Feb;
26(1):25.
PMID: 38326868
Background: There is increasing evidence that artificial intelligence (AI) breast cancer risk evaluation tools using digital mammograms are highly informative for 1-6 years following a negative screening examination. We hypothesized...
7.
Cuzick J, Chu K, Keevil B, Brentnall A, Howell A, Zdenkowski N, et al.
Lancet Oncol
. 2023 Dec;
25(1):108-116.
PMID: 38070530
Background: An increased risk of breast cancer is associated with high serum concentrations of oestradiol and testosterone in postmenopausal women, but little is known about how these hormones affect response...
8.
Brentnall A, Cuschieri K, Sargent A, Berkhof J, Rebolj M
J Clin Epidemiol
. 2023 Dec;
166:111227.
PMID: 38065518
Objectives: To ensure that the emerging methods for human papillomavirus (HPV) testing on self-collected samples in cervical screening are evaluated robustly. Study Design And Setting: We assess paired study designs...
9.
Brentnall A, Atakpa E, Hill H, Santeramo R, Damiani C, Cuzick J, et al.
NPJ Digit Med
. 2023 Nov;
6(1):223.
PMID: 38017184
It is uncommon for risk groups defined by statistical or artificial intelligence (AI) models to be chosen by jointly considering model performance and potential interventions available. We develop a framework...
10.
Atakpa E, Buist D, Aiello Bowles E, Cuzick J, Brentnall A
Breast Cancer Res
. 2023 Nov;
25(1):147.
PMID: 38001476
Background: Women with dense breasts have an increased risk of breast cancer. However, breast density is measured with variability, which may reduce the reliability and accuracy of its association with...